Clinical Trial

Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)

Study acronym: ACROBAT
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2025 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Open-label, randomized multicenter phase III non-inferiority study
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-11-29; most recent amendment 2025-04-28.
Status change: Not Yet Recruiting → Recruiting 2022-10-10
Trial Details
NCT Number NCT04184505
Lead Sponsor Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions High-risk MDS
Enrollment 274 participants
Start Date 2020-11-27
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-29